Advance your project with our biomarker discovery expertise
Our dedicated team works to identify and validate pharmacodynamic, target engagement and selection biomarkers using preclinical in vitro and in vivo models, tailored to your needs. We profile the clinical indication space with our tissue biobank to pinpoint patient populations relevant to your research. By leveraging biomarkers, we provide valuable insights into the pharmacokinetic/ pharmacodynamic (PK/PD) relationship of novel drug candidates. Additionally, we analyse biomarkers from your clinical trial samples to help ensure seamless translation of preclinical findings to clinical applications.




